Changing from glucose to HbA1c for diabetes diagnosis: Predictive values of one test and importance of analytical bias and imprecision

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 7, 2014, Pages 1069-1077

  Nielsen, Aneta Aleksandra ^a   Petersen, Per Hyltoft ^b   Green, Anders ^c   Christensen, Cramer ^a   Christensen, Henry ^a   Brandslund, Ivan ^c  

^a LILLEBAELT HOSPITAL   (Denmark)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Analytical bias; Analytical variation; Diabetes mellitus; Fasting plasma glucose; Glycated haemoglobin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; DENMARK; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; ANALYSIS; BLOOD; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; STATISTICAL BIAS;

ADULT; AGED; BIAS (EPIDEMIOLOGY); BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84903729746     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0337     Document Type: Article

References (43)

1. Standards of medical care in diabetes - 2010. Diabetes Care 2010;33(Suppl 1):11-61.
2. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-34.
3. Notat vedrørende diagnostik af diabetes mellitus med HbA1c (Note on diagnosis of diabetes mellitus with HbA1c - Translation from Danish). Available from: http://www.sst.dk/media/Planlaegning%20og%20kvalitet/Diabetes/ Diagnosticering/DiagnosticeringType2Diabetes.ashx. Accessed on 2 February, 2013.
4. Hoelzel W, Miedema K. Development of a reference system for the international standardization of HbA1c/glycohemoglobin determinations. J Int Fed Clin Chem 1996;9:62-4, 66-7.
5. Jeppsson J-O, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 2002;40:78-89.
6. Finke A, Kobold U, Hoelzel W, Weykamp C, Miedema K, Jeppsson JO. Preparation of a candidate primary reference material for the international standardisation of HbA1c determinations. Clin Chem Lab Med 1998;36:299-308.
7. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007;30:2399-400.
8. Hanas R, John G. 2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 2010;33:1903-4.
9. Hoelzel W, Weykamp C, Jeppsson J-O, Miedema K, Barr JR, Goodall I, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: A method-comparison study. Clin Chem 2004;50:166-74.
10. Nordin G. Coefficient of variation for hemoglobin A1c results that are traceable to national glycohemoglobin standardization program must be distinguished from coefficient of variation for results traceable to International Federation of Clinical Chemistry and Laboratory Medicine. Diabetes Technol Ther 2011;13:1271-2.
11. Weykamp CW, Mosca A, Gillery P, Panteghini M. The analytical goals for hemoglobin A1c measurement in IFCC units and national glycohemoglobin standardization program units are different. Clin Chem 2011;57:1204-6.
12. Desirable biological variation database specifications - Westgard QC. Available from: http://www.westgard.com/biodatabase1.htm. Accessed on 27 November, 2012.
13. Stahl M, Jørgensen LG, Hyltoft Petersen P, Brandslund I, de Fine Olivarius N, Borch-Johnsen K. Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001;61:169-79.
14. Little RR, Rohlfing CL, Tennill AL, Connolly S, Hanson S. Effects of sample storage conditions on glycated hemoglobin measurement: evaluation of five different high performance liquid chromatography methods. Diabetes Technol Ther 2007;9:36-42.
15. Rohlfing C, Wiedmeyer H-M, Little R, Grotz VL, Tennill A, England J, et al. Biological variation of glycohemoglobin. Clin Chem 2002;48:1116-8.
16. Carlsen S, Petersen PH, Skeie S, Skadberg Ø, Sandberg S. Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients. Clin Chem Lab Med 2011;49:1501-7.
17. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011;34:61-99.
18. WHO/International Classification of Diseases 10th Revision. Available from: http://apps.who.int/classifications/icd10/browse/2010/en. Accessed on 11 April, 2012.
19. Green A, Gustav P. Internal documentation. Research Unit of Clinical Epidemiology, University of Southern Denmark, Centre for National Clinical Databases, South.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
21. Dansk Institut for ekstern kvalitetssikring for laboratorier i sundhedssektoren (Quality assurance for laboratories in health care - Translation from Danish). Available from: http://www.deks.dk/index1.html. Accessed on 22 January, 2013.
22. International EQAS - Ensuring excellent results - Labquality. Available from: http://www.labquality.fi/eqa-eqas/Accessed on 22 January, 2013.
23. Kvalitetssikring af laboratoriemedicinske aktiviteter i almen praksis (Danish Society for General Practice - Translation from Danish). Available from: http://www.dsam.dk/files/13/kvalitetssikring-og-kvalitetskrav-2010-ark.pdf. Accessed on 8 February, 2013.
24. WHO: Global database on body mass index. Available from: http://apps.who.int/bmi/index.jsp?introPage=intro-3.html. Accessed on 1 August, 2012.
25. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-31.
26. Blake GJ, Pradhan AD, Manson JE, Williams GR, Buring J, Ridker PM, et al. Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med 2004;164:757-61.
27. Gao L, Matthews FE, Sargeant LA, Brayne C. An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study. BMC Public Health 2008;8:54.
28. Stavelin A, Petersen PH, Sølvik U, Sandberg S. Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. Thromb Haemost 2009;102:593-600.
29. Røraas T, Petersen PH, Sandberg S. Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals. Clin Chem 2012;58:1306-13.
30. McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. Br Med J 1994;308:1323-8.
31. Petersen PH, Brandslund I, Jørgensen L, Stahl M, Olivarius ND, Borch-Johnsen K. Evaluation of systematic and random factors in measurements of fasting plasma glucose as the basis for analytical quality specifications in the diagnosis of diabetes. 3. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001;61:191-204.
32. Jørgensen LG, Stahl M, Brandslund I, Hyltoft Petersen P, Borch- Johnsen K, de Fine Olivarius, N. Plasma glucose reference interval in a low-risk population. 2. Impact of the new WHO and ADA recommendations on the diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001;61:181-90.
33. Jørgensen LG, Brandslund I, Stahl M, Hyltoft Petersen P, Iversen S, Klitgaard N, et al. Upper reference limit, analytical quality specifications and clinical use of haemoglobin A1C. Scand J Clin Lab Invest 2002;62:609-22.
34. Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS, et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008;31:1991-6.
35. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-8.
36. Davidson MB, Schriger DL, Peters AL, Lorber B. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 1999;281:1203-10.
37. Glümer C, Jørgensen T, Borch-Johnsen K. Prevalences of diabetes and impaired glucose regulation in a Danish population: The Inter99 study. Diabetes Care 2003;26:2335-40.
38. Gusto G, Vol S, Born C, Balkau B, Lamy J, Bourderioux C, et al. [Age and sex variations of HbA(1C) in a French population without known diabetes aged 6 to 79 years]. Ann Biol Clin (Paris) 2011;69:545-53.
39. Bernal-Lopez MR, Santamaría-Fernandez S, Lopez-Carmona D, Tinahones FJ, Mancera-Romero J, Peña-Jimenez D, et al. HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice. Diabet Med 2011;28:1319-22.
40. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010;33:562-8.
41. Hayes L, Hawthorne G, Unwin N. Undiagnosed diabetes in the over-60s: performance of the Association of Public Health Observatories (APHO) Diabetes Prevalence Model in a general practice. Diabet Med 2012;29:115-20.
42. Scientific Committee on Quality Assurance (VUK), Analysekvalitetskrav til HbA1c ved brug til diagnostik og monitorering af diabetes (Analytical Quality of HbA1c when used for diagnosis and monitoring of diabetes - Translation from Danish), Available fromhttp://www.dskb.dk/media/documents/VUK%20HbA1c.doc. Accessed on 2 March, 2012.
43. College of American Pathologists (CAP) GH2 Survey Data. Available from: http://www.ngsp.org/CAP/CAP12a.pdf. Accessed on 12 February, 2013.